EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 142 filers reported holding EPIZYME INC in Q4 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $66,908 | -41.5% | 26,763 | +19.7% | 0.00% | -50.0% |
| Q3 2021 | $114,447 | -31.9% | 22,353 | +10.5% | 0.00% | 0.0% |
| Q2 2021 | $168,028 | -18.9% | 20,220 | -15.0% | 0.00% | -33.3% |
| Q1 2021 | $207,159 | -16.9% | 23,784 | +3.7% | 0.00% | -25.0% |
| Q4 2020 | $249,161 | -24.3% | 22,943 | -16.9% | 0.00% | -33.3% |
| Q3 2020 | $329,280 | -25.7% | 27,601 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $443,272 | +22.4% | 27,601 | +18.2% | 0.01% | 0.0% |
| Q1 2020 | $362,143 | -42.2% | 23,349 | -8.4% | 0.01% | -20.0% |
| Q4 2019 | $626,734 | +131.9% | 25,477 | -2.8% | 0.01% | +100.0% |
| Q3 2019 | $270,315 | +0.6% | 26,206 | +22.4% | 0.01% | 0.0% |
| Q2 2019 | $268,657 | +10.8% | 21,407 | +9.4% | 0.01% | +25.0% |
| Q1 2019 | $242,472 | +138.0% | 19,570 | +18.3% | 0.00% | +100.0% |
| Q4 2018 | $101,893 | -41.9% | 16,541 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $175,335 | -99.9% | 16,541 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $224,131,000 | -20.4% | 16,541 | +4.2% | 0.00% | 0.0% |
| Q1 2018 | $281,710,000 | +141462.8% | 15,871 | 0.0% | 0.00% | +33.3% |
| Q4 2017 | $199,000 | -65.9% | 15,871 | -48.3% | 0.00% | -25.0% |
| Q3 2017 | $584,000 | +26.1% | 30,680 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $463,000 | -12.0% | 30,680 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $526,000 | +41.8% | 30,680 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $371,000 | +37.4% | 30,680 | +11.9% | 0.00% | +50.0% |
| Q3 2016 | $270,000 | -15.1% | 27,411 | -11.8% | 0.00% | 0.0% |
| Q2 2016 | $318,000 | -15.6% | 31,085 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $377,000 | +14.2% | 31,085 | +50.9% | 0.00% | 0.0% |
| Q4 2015 | $330,000 | +24.5% | 20,594 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $265,000 | -48.0% | 20,594 | -3.0% | 0.00% | -50.0% |
| Q2 2015 | $510,000 | +164.2% | 21,241 | +106.6% | 0.00% | +300.0% |
| Q1 2015 | $193,000 | -0.5% | 10,282 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $194,000 | -30.5% | 10,282 | 0.0% | 0.00% | -50.0% |
| Q3 2014 | $279,000 | -12.8% | 10,282 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $320,000 | +91.6% | 10,282 | +147.5% | 0.00% | +100.0% |
| Q3 2013 | $167,000 | -21.6% | 4,154 | -45.2% | 0.00% | -50.0% |
| Q2 2013 | $213,000 | – | 7,581 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |